American Century Companies’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $911K | Buy |
132,349
+8,638
| +7% | +$59.4K | ﹤0.01% | 2327 |
|
|
2025
Q1 | $356K | Buy |
123,711
+3,100
| +3% | +$8.93K | ﹤0.01% | 2625 |
|
|
2024
Q4 | $567K | Buy |
120,611
+6,770
| +6% | +$31.8K | ﹤0.01% | 2458 |
|
|
2024
Q3 | $406K | Buy |
113,841
+9,470
| +9% | +$33.8K | ﹤0.01% | 2545 |
|
|
2024
Q2 | $647K | Buy |
104,371
+12,167
| +13% | +$75.4K | ﹤0.01% | 2346 |
|
|
2024
Q1 | $870K | Buy |
92,204
+27,581
| +43% | +$260K | ﹤0.01% | 2208 |
|
|
2023
Q4 | $436K | Buy |
64,623
+27,684
| +75% | +$187K | ﹤0.01% | 2418 |
|
|
2023
Q3 | $164K | Buy |
36,939
+8,522
| +30% | +$37.8K | ﹤0.01% | 2635 |
|
|
2023
Q2 | $93.8K | Buy |
28,417
+8,214
| +41% | +$27.1K | ﹤0.01% | 2688 |
|
|
2023
Q1 | $57.2K | Buy |
+20,203
| New | +$57.2K | ﹤0.01% | 2612 |
|